A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer.
9
mentions
- X 7
- YouTube 2
PubHawk tracks social media discussions for 3 articles by authors named Yuting Wang.
Mentions
Extended reach
Total likes
Video views
Tracked by PubHawk
From PubMed
Searching PubMed…